Atezolizumab with pre-surgery brain radiation for glioblastoma
Part of Cancer clinical trials.
This early-phase study tests atezolizumab (an immune therapy) together with radiation before brain surgery for glioblastoma. It aims to make the treatment safer and more effective before the tumor is removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glioblastoma that is WHO grade 4
- Your doctors plan surgery with the goal to remove more than 80% of the tumor
- You can safely receive treatment and you have adequate blood/organ function
- You are at a good overall health level (ECOG 2 or less)
- The tumor size is small enough (up to 3.5 cm volume limit)
- You do not have certain infections, including HIV, hepatitis B, hepatitis C, and tuberculosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving radiation and chemotherapy before surgery for glioblastoma. It aims to see if this approach is safe and may help improve outcomes for patients whose tumor can be completely removed.
This Phase 1 study tests whether adding an immune therapy called retifanlimab to radiation (and a chemotherapy medicine called temozolomide, in some parts of the study) is safe and helpful for newly diagnosed glioblastoma patients after surgery with carmustine wafers. It aims to see how well this combination controls the cancer and what side effects are expected.
This trial tests a cancer-immunotherapy medicine (an anti–PD-1 antibody, similar to pembrolizumab) combined with precisely targeted radiation to treat glioblastoma that has come back or progressed. It may help your immune system recognize and attack the tumor while the radiation targets the cancer.
This trial tests giving a chemotherapy drug called temozolomide before radiation therapy to people with a newly diagnosed high-grade brain tumor. The goal is to see if this approach can help control the tumor better.
This trial tests a new way of giving radiation therapy for glioblastoma (a type of brain cancer) using a machine that combines MRI imaging with radiation. The goal is to safely intensify the treatment and improve outcomes.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
Hear when a new Glioblastoma Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.